Franklin Resources’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Buy |
140,182
+61,155
| +77% | +$1.33M | ﹤0.01% | 1551 |
|
|
2025
Q1 | $1.92M | Buy |
79,027
+20,544
| +35% | +$498K | ﹤0.01% | 1699 |
|
|
2024
Q4 | $1.22M | Sell |
58,483
-681
| -1% | -$14.2K | ﹤0.01% | 1894 |
|
|
2024
Q3 | $1.22M | Buy |
59,164
+1,967
| +3% | +$40.6K | ﹤0.01% | 1896 |
|
|
2024
Q2 | $886K | Sell |
57,197
-168,859
| -75% | -$2.62M | ﹤0.01% | 1972 |
|
|
2024
Q1 | $3.6M | Buy |
226,056
+40,133
| +22% | +$640K | ﹤0.01% | 1484 |
|
|
2023
Q4 | $3.13M | Buy |
185,923
+33,397
| +22% | +$561K | ﹤0.01% | 1249 |
|
|
2023
Q3 | $1.78M | Buy |
152,526
+28,327
| +23% | +$331K | ﹤0.01% | 1421 |
|
|
2023
Q2 | $1.67M | Buy |
124,199
+19,770
| +19% | +$266K | ﹤0.01% | 1466 |
|
|
2023
Q1 | $1.73M | Buy |
104,429
+394
| +0.4% | +$6.53K | ﹤0.01% | 1394 |
|
|
2022
Q4 | $1.94M | Sell |
104,035
-31,933
| -23% | -$594K | ﹤0.01% | 1369 |
|
|
2022
Q3 | $1.74M | Sell |
135,968
-382
| -0.3% | -$4.9K | ﹤0.01% | 1389 |
|
|
2022
Q2 | $956K | Buy |
136,350
+84,262
| +162% | +$591K | ﹤0.01% | 1548 |
|
|
2022
Q1 | $432K | Buy |
+52,088
| New | +$432K | ﹤0.01% | 1885 |
|
|
2016
Q1 | – | Sell |
-2,127,100
| Closed | -$5.21M | – | 1520 |
|
|
2015
Q4 | $5.21M | Hold |
2,127,100
| – | – | ﹤0.01% | 1123 |
|
|
2015
Q3 | $6.38M | Sell |
2,127,100
-384,500
| -15% | -$1.15M | ﹤0.01% | 1102 |
|
|
2015
Q2 | $10.4M | Hold |
2,511,600
| – | – | ﹤0.01% | 1032 |
|
|
2015
Q1 | $10.9M | Hold |
2,511,600
| – | – | ﹤0.01% | 1035 |
|
|
2014
Q4 | $7.46M | Hold |
2,511,600
| – | – | ﹤0.01% | 1104 |
|
|
2014
Q3 | $8.34M | Sell |
2,511,600
-77,900
| -3% | -$259K | ﹤0.01% | 1073 |
|
|
2014
Q2 | $6.55M | Buy |
+2,589,500
| New | +$6.55M | ﹤0.01% | 1135 |
|